Immunic, Inc.
IMUX· Nasdaq
Released May 8, 2024, before the open
10-Q filed May 8, 2024, 38 days after period end · 0001280776-24-000009
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$29.58M | -$25.27M | -$20.81M | -$34.53M |
| EPS Diluted | -$0.30 | -$0.58 | -$0.74 | -$1.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR